sponsored 24 August 2018

Time to rethink corticosteroids for COPD

Sponsored This content has been produced by Australian Doctor Group with an independent educational grant from Boehringer Ingelheim.
Therapy Update 18 July 2018 Dr Bernadette Prentice, Professor Adam Jaffe, Dr Shafagh Waters

Avatars take lead role in future CF therapy

Under the bright lights of a lab, a cluster of human cells inside a dish is exposed to a novel — and expensive — drug to test its efficacy.
Therapy Update 30 May 2018 Dr Clare Wood, Associate Professor Deborah Yates

Work-related interstitial lung disease

There has been a great deal of media interest in recent years about interstitial diseases of the lung caused by exposure to dusts in an occupational setting.1
How to Treat 02 May 2018 Professor Graeme Maguire, Dr Alistair Miller
How to Treat 27 April 2018 Professor Graeme Maguire, Dr Alistair Miller
Case Report 16 April 2018 Dr Daniel Xu

A patient with asthma develops reflux

Norma is a 64-year-old accountant. She attends with a classical infective exacerbation of asthma with wheeze, productive cough and increasing shortness of breath on exertion.
How to Treat 06 April 2018 Dr Helen Jo, Associate Professor Tamera Corte
Clinical Audit 15 March 2018 Australian Doctor Education

Controlling symptomatic asthma

Patients with severe asthma account for more than 60% of the costs associated with asthma, which are primarily for medications.
How to Treat 01 February 2018 Yasmeen Al-Hindawi, Associate Professor Deborah Yates
Therapy Update 13 November 2017 Dr Anup Desai

Nocturnal hypoventilation

Sleep disorders are common and often unaddressed. One of the barriers to successful management is awareness of the conditions, both at a doctor and patient level.